PERMANENT TSB GROUP HOLDINGS PLC (PTSB)
Irish Exchange · Ireland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 2.980 |
|---|---|
| 52-week range | 2.280 – 3.280 |
| Return, 1 month / 3 months | +0.3% / −1.7% |
| Return, 1 year / 3 years | +30.4% / +49.9% |
| Trend | Below its 200-day average |
| RSI (14) | 49 |
| Volatility (1 year) | 29.3% |
| Worst drawdown (1 year) | -14.3% |
| Average daily value traded | 1.26M EUR |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Permanent TSB Group Holdings is an Irish retail bank based in Dublin. It provides mortgages, current and deposit accounts, personal loans and related banking services to households and small businesses across Ireland. The bank serves personal customers through its branch network and online and mobile channels, and it also offers some business banking and insurance-related products. Its main market is the Republic of Ireland, where it operates as a domestic retail and small business lender.
PERMANENT TSB GROUP HOLDINGS PLC trades under the code PTSB on the Irish Exchange in Ireland, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PERMANENT TSB GROUP HOLDINGS PLC (PTSB) trades on the Irish Exchange in Ireland. It last closed at EUR 2.980 on 22 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 14 of 21 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 30.4% and over the last three months it fell 1.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Irish Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 40 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.0% | ||
| From 52-week high | -7.7% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.7% | ||
| 6-month return | 2.4% | ||
| 12-month return, skipping the last month | 29.9% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.3% | ||
| Liquidity | 48 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 1.26M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 17 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | +0.3% |
| 3 months | −1.7% |
| 6 months | +2.4% |
| 1 year | +30.4% |
| 3 years | +49.9% |
| 5 years | +97.3% |
Signals
| 50-day / 200-day average | 2.965 / 2.981 |
|---|---|
| Golden / death cross (60 days) | Death, 30 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.026 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Apr 2026 | EUR 0.0184 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Irish Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.